Mitoxantrone Versus Daunorubicin in Induction-Consolidation Chemotherapy-The Value of Low-Dose Cytarabine for Maintenance of Remission, and an Assessment …
B Löwenberg, S Suciu, E Archimbaud… - Journal of Clinical …, 1998 - orbi.uliege.be
B Löwenberg, S Suciu, E Archimbaud, H Haak, P Stryckmans, R De Cataldo, AW Dekker…
Journal of Clinical Oncology, 1998•orbi.uliege.beConclusion: In previously untreated elderly patients with AML, MTZ induction therapy
produces a slightly better CR rate than does a DNR-containing regimen, but it has no
significant effect on remission duration and survival. Ara-C in maintenance may prolong
DFS, but it did not improve survival.
produces a slightly better CR rate than does a DNR-containing regimen, but it has no
significant effect on remission duration and survival. Ara-C in maintenance may prolong
DFS, but it did not improve survival.
Conclusion: In previously untreated elderly patients with AML, MTZ induction therapy produces a slightly better CR rate than does a DNR-containing regimen, but it has no significant effect on remission duration and survival. Ara-C in maintenance may prolong DFS, but it did not improve survival.
orbi.uliege.be